Twist Bioscience Corporation Common Stock
Twist Bioscience Corporation Common Stock price
About Twist Bioscience Corporation Common Stock
Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
- Stock ticker
- TWST
- Company
- Twist Bioscience Corporation
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- --
- Launch date
- Oct 31, 2018
- Listed exchange
- NASDAQ
Financials
Summary: TWST reported Revenue of 118.40M (+23.26%), beating expectations; EPS of -0.56 (-19.15%), missing expectations.
Twist Bioscience Corporation Common Stock conversion tables
 |  |
|---|---|
| 0.5 TWST | 77.78 USD |
| 1 TWST | 155.56 USD |
| 5 TWST | 777.8 USD |
| 10 TWST | 1,555.6 USD |
| |
|---|---|
| 0.5 USD | 0.0032142 TWST |
| 1 USD | 0.0064284 TWST |
| 5 USD | 0.032142 TWST |
| 10 USD | 0.064284 TWST |
More to explore
FAQ
TWST is trading at $155.56, -0.06% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TWST stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TWST is currently trading at $155.56, -0.06% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TWST price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TWST's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TWST; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TWST's historical range and other companies in the Healthcare sector.
Twist Bioscience Corporation's market cap is currently 10.02B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.